Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2251
Knowles
KN
$3.12B
| $1.74M | ﹤0.01% |
114,000
-226,574
| -67% | -$3.38M |
2017 Q1
13 quarters
|
|
2252
Team
TISI
$121M
| $1.74M | ﹤0.01% |
31,153
+20,404
| +190% | +$1.13M |
2019 Q2
4 quarters
|
|
2253
NetSol Technologies
NTWK
$74.3M
| $1.73M | ﹤0.01% |
640,242
+96,118
| +18% | +$263K |
2014 Q3
23 quarters
|
|
2254
Matthews International
MATW
$582M
| $1.73M | ﹤0.01% |
+90,353
| New | +$1.93M |
2020 Q2
0 quarters
|
|
2255
DELISTED
Xoma
XOMA
| $1.73M | ﹤0.01% |
87,369
-20,217
| -19% | -$444K |
2019 Q4
2 quarters
|
|
2256
TPG RE Finance Trust
TRTX
$448M
| $1.72M | ﹤0.01% |
200,317
-1,365,200
| -87% | -$9.92M |
2018 Q3
7 quarters
|
|
|
WDR
2257
DELISTED
Waddell & Reed Financial, Inc.
WDR
| $1.72M | ﹤0.01% |
+111,000
| New | +$1.52M |
2020 Q2
0 quarters
|
|
|
NM
2258
DELISTED
Navios Maritime Holdings Inc.
NM
| $1.71M | ﹤0.01% |
808,744
-8,200
| -1% | -$17.8K |
2015 Q4
18 quarters
|
|
2259
Alector
ALEC
$232M
| $1.71M | ﹤0.01% |
+69,780
| New | +$1.93M |
2020 Q2
0 quarters
|
|
2260
Schwab US Large- Cap ETF
SCHX
$75.3B
| $1.7M | ﹤0.01% |
138,000
+55,200
| +67% | +$643K |
2019 Q4
2 quarters
|
|
2261
iShares Latin America 40 ETF
ILF
$4.16B
| $1.7M | ﹤0.01% |
78,800
+38,400
| +95% | +$772K |
2020 Q1
1 quarter
|
|
|
TGA
2262
DELISTED
Transglobe Energy Corp
TGA
| $1.7M | ﹤0.01% |
2,971,467
+23,900
| +0.8% | +$12.4K |
2014 Q2
24 quarters
|
|
|
OPNT
2263
DELISTED
Opiant Pharmaceuticals, Inc. Common Stock
OPNT
| $1.7M | ﹤0.01% |
187,970
+126,742
| +207% | +$1.31M |
2019 Q3
3 quarters
|
|
2264
Eagle Bancorp
EGBN
$866M
| $1.7M | ﹤0.01% |
51,785
-31,200
| -38% | -$995K |
2018 Q2
8 quarters
|
|
2265
High Templar Tech Ltd
HTT
$349M
| $1.7M | ﹤0.01% |
996,923
+62,830
| +7% | +$104K |
2020 Q1
1 quarter
|
|
|
FCCY
2266
DELISTED
1st Constitution Bancorp
FCCY
| $1.69M | ﹤0.01% |
136,494
+1,724
| +1% | +$21.1K |
2016 Q4
14 quarters
|
|
2267
Invesco China Technology ETF
CQQQ
$2.4B
| $1.69M | ﹤0.01% |
26,600
+13,300
| +100% | +$730K |
2020 Q1
1 quarter
|
|
2268
Under Armour Class C
UA
$2.06B
| $1.68M | ﹤0.01% |
190,100
-1,455,543
| -88% | -$12.4M |
2020 Q1
1 quarter
|
|
2269
Cytokinetics
CYTK
$8.73B
| $1.68M | ﹤0.01% |
+71,067
| New | +$1.33M |
2020 Q2
0 quarters
|
|
2270
Caledonia Mining Corp
CMCL
$466M
| $1.67M | ﹤0.01% |
96,410
+84,910
| +738% | +$1.18M |
2019 Q1
5 quarters
|
|
2271
World Kinect Corp
WKC
$1.85B
| $1.67M | ﹤0.01% |
64,773
-722,600
| -92% | -$17.8M |
2018 Q4
6 quarters
|
|
2272
DELISTED
HMN Financial Inc
HMNF
| $1.66M | ﹤0.01% |
114,000
+3,900
| +4% | +$59.4K |
2013 Q2
28 quarters
|
|
2273
BellRing Brands
BRBR
$999M
| $1.66M | ﹤0.01% |
+83,400
| New | +$1.55M |
2020 Q2
0 quarters
|
|
|
MLVF
2274
DELISTED
Malvern Bancorp, Inc.
MLVF
| $1.66M | ﹤0.01% |
130,164
+29,400
| +29% | +$347K |
2016 Q4
14 quarters
|
|
2275
Hasbro
HAS
$13.4B
| $1.66M | ﹤0.01% |
22,100
-446,541
| -95% | -$32.3M |
2019 Q4
2 quarters
|
|
Similar funds
Renaissance Technologies's Q2 2020 Portfolio in Review
As of Q2 2020, Renaissance Technologies held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Renaissance Technologies withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,365 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Renaissance Technologies opened a new position in Uber worth $187M.
- Renaissance Technologies's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Renaissance Technologies added most to Zoom in Q2 2020, an estimated $806M increase.
- Renaissance Technologies's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Renaissance Technologies fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Renaissance Technologies's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Renaissance Technologies opened 584 new positions and closed 596 in Q2 2020.
- Renaissance Technologies's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.